Responses
Correspondence
Correspondence on ‘No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related ‘physician-reported spondylitis’?’
Compose a Response to This Article
Other responses
No responses have been published for this article.